Drug intelligence / Profile preview

Renervix

Development stage
Unknown
Lead developer
Alfa Intes
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Renervix is an ophthalmic gel medical device developed by Alfa Intes for corneal neuroprotection and nerve regeneration. The formulation contains 0.3% cross-linked hyaluronic acid, which provides prolonged lubrication and viscoelastic support by adhering to the corneal surface for an extended period. It is enriched with a nutrient complex including vitamin B12 (cyanocobalamin) to accelerate corneal re-epithelialization, vitamin B6 (pyridoxamine) to stimulate the regrowth of corneal nerve endings, and taurine to support nerve health and neutralize oxidative stress in epithelial cells. Renervix is primarily indicated to support the physiological repair of the cornea and promote reinnervation following anterior segment surgery or corneal abrasions.

Brand names
Renervix

Beyond the preview

Go deeper on Renervix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renervix.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call